Sidney Taurel
Sidney Taurel
Sidney Taurelis a Moroccan-born American businessman. He is the former Chairman and Chief Executive Officer of Eli Lilly and Company. He became chief executive officer in July 1998 and chairman of the board of directors on January 1, 1999. He was succeeded as chief executive officer by John C. Lechleiter on April 1, 2008. He now serves as an advisor at Moelis & Company...
dose patient
the right dose of the right drug to the right patient at the right time.
broad built business challenges charlie company financial help internal judgment past reputation sound steer strong
During his tenure, Charlie used his broad business experiences and sound judgment to help steer the company through many challenges over the past decade. Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations, transparency in our financial reporting, and strong internal controls.
appeals asking case decision fails option supreme
We are asking for a rehearing on the decision by the appeals court, and if that fails we have the option of going to the Supreme Court, so the case is not over,
adjusted anticipate average compared consensus deliver double earnings expect expected fact forecast given growth major nearly patent per rate represents rest share street sustained uniquely wall
Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of $3.10 to $3.20, which represents 8% to 12% growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies.
address bring closely committing company continue deliver fda innovative medicines necessary order patients promise quickly resources work
I am committing all the necessary resources of the company to address these issues, ... We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible.
destiny execute help structure
Now that we've done all this, our destiny is in our hands. It's up to us to perform. This new structure will help us better execute our strategy.
building importance launching pipeline quarter strong
While the first quarter was a challenging quarter, it underscores the importance of building a strong pipeline and effectively launching new products,
believe confirm iii looks phase seen successful trials
It looks very, very promising, ... We believe that if the Phase III trials confirm what we have seen so far, this would be a very successful product.
abide actions activities although assure business charged committed continue deeply designed ensuring ethical federal fully governing government highest laws legal practices reflect regret remain resulted seriously standards steps
We deeply regret the 1998 conduct, which has resulted in a federal misdemeanor charge. We take seriously our responsibilities to abide by all the laws governing our business practices and are committed to ensuring our employees' actions reflect the highest legal and ethical standards of conduct. Although the government has not charged Lilly with any unlawful intent, we will continue to take steps designed to assure that Lilly's promotional activities remain fully compliant.
access affordable best care disaster ensure founders health nearly needing patients people survivors values whether
Whether they are patients needing access to affordable health care or survivors of a disaster, we do our best to ensure that people in need are not forgotten. Our founders established these values nearly 130 years ago, and we live by them today.
data erosion months nearly product prozac sales severe
With nearly two months of Prozac sales data available, the erosion in prescriptions is the most severe ever for a blockbuster product in our industry,
built class financial reputation sound
Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations.
completion confidence continued future high initiation level rapid reflect share
The rapid completion of the share repurchase program, coupled with the initiation of a new program, reflect the board's continued high level of confidence in the future of the company.
lives saving thousands
We're going to be saving hundreds of thousands of lives with this product,